Julia is the founder and CEO of PuraCath Medical, a medical device company focused on improving efficacy of catheter connection to enhance the quality of life for both patients and healthcare providers. She has over twenty years of experience in R&D in medical device and biotech industries. Under her leadership, PuraCath Medical received three FDA clearances for the family of Firefly® Disinfection Systems. She is focused on revolutionizing the hospital industry with a novel ultraviolet technology to help reduce hospital acquired infections from catheter lines. She also worked as a Venture Partner for overseas family offices, in conjunction with being an angel investor, and invested in funds and direct deals in healthcare, tech, and fintech. Julia has obtained a B.Sc. in Bioengineering from the University of California Berkeley, an M.S. in Bioengineering from Stanford University, an M.S. in Medicine from Stanford University, and a Certificate from the Summer Institute for Entrepreneurship from the Stanford Graduate School of Business (GSB). She took a “leave‐of‐absence” from her PhD program in Bioengineering from Stanford University to grow PuraCath on a full-time basis. She has won multiple honors and awards, including the Howard Hughes Medical Institute Medical Scholar, the National Ford Foundation Pre-Doctoral Fellowship, the National Coca-Cola Scholarship, and multiple other prestigious governmental grants from NIH, NSF, and DOD for her ventures.
